Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.

dc.contributor.author

Eichenberger, Emily M

dc.contributor.author

Ruffin, Felicia

dc.contributor.author

Dagher, Michael

dc.contributor.author

Lerebours, Reginald

dc.contributor.author

Jung, Sin-Ho

dc.contributor.author

Sharma-Kuinkel, Batu

dc.contributor.author

Macintyre, Andrew N

dc.contributor.author

Thaden, Joshua T

dc.contributor.author

Sinclair, Matthew

dc.contributor.author

Hale, Lauren

dc.contributor.author

Kohler, Celia

dc.contributor.author

Palmer, Scott M

dc.contributor.author

Alexander, Barbara D

dc.contributor.author

Fowler, Vance G

dc.contributor.author

Maskarinec, Stacey A

dc.date.accessioned

2022-02-01T20:02:06Z

dc.date.available

2022-02-01T20:02:06Z

dc.date.issued

2021-06

dc.date.updated

2022-02-01T20:02:05Z

dc.description.abstract

We undertook a prospective, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteristics, outcomes, and chemokine and cytokine response in transplant recipients to immunocompetent, nontransplant recipients. Fifty-five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysis. Transplant GNB had a significantly lower incidence of septic shock than nontransplant GNB (10.3% vs 30.7%, p = .03). Thirty-day mortality did not differ significantly between transplant and nontransplant recipients with GNB (10.3% vs 15.8%, p = .57) or SAB (0.0% vs 11.7%, p = .13). Next, transplant patients were matched 1:1 with nontransplant patients for the chemokine and cytokine analysis. Five cytokines and chemokines were significantly lower in transplant GNB vs nontransplant GNB: IL-2 (median [IQR]: 7.1 pg/ml [7.1, 7.1] vs 32.6 pg/ml [7.1, 88.0]; p = .001), MIP-1β (30.7 pg/ml [30.7, 30.7] vs 243.3 pg/ml [30.7, 344.4]; p = .001), IL-8 (32.0 pg/ml [5.6, 53.1] vs 59.1 pg/ml [39.2, 119.4]; p = .003), IL-15 (12.0 pg/ml [12.0, 12.0] vs 12.0 pg/ml [12.0, 126.7]; p = .03), and IFN-α (5.1 pg/mL [5.1, 5.1] vs 5.1 pg/ml [5.1, 26.3]; p = .04). Regulated upon Activation, Normal T Cell Expressed and Secreted (RANTES) was higher in transplant SAB vs nontransplant SAB (mean [SD]: 750.2 pg/ml [194.6] vs 656.5 pg/ml [147.6]; p = .046).

dc.identifier.issn

1600-6135

dc.identifier.issn

1600-6143

dc.identifier.uri

https://hdl.handle.net/10161/24331

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

dc.relation.isversionof

10.1111/ajt.16388

dc.subject

Humans

dc.subject

Bacteremia

dc.subject

Cytokines

dc.subject

Organ Transplantation

dc.subject

Cohort Studies

dc.subject

Prospective Studies

dc.subject

Transplant Recipients

dc.title

Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.

dc.type

Journal article

duke.contributor.orcid

Eichenberger, Emily M|0000-0002-2469-0638

duke.contributor.orcid

Ruffin, Felicia|0000-0003-2176-6462

duke.contributor.orcid

Lerebours, Reginald|0000-0003-2884-3168

duke.contributor.orcid

Jung, Sin-Ho|0000-0002-1473-7236

duke.contributor.orcid

Macintyre, Andrew N|0000-0002-5297-0207

duke.contributor.orcid

Thaden, Joshua T|0000-0002-3250-0697

duke.contributor.orcid

Sinclair, Matthew|0000-0002-8003-9786

duke.contributor.orcid

Palmer, Scott M|0000-0002-1370-3771

duke.contributor.orcid

Alexander, Barbara D|0000-0001-5868-0529

duke.contributor.orcid

Fowler, Vance G|0000-0002-8048-0897

pubs.begin-page

2113

pubs.end-page

2122

pubs.issue

6

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Staff

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Immunology

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Medicine, Duke Human Vaccine Institute

pubs.organisational-group

Medicine, Infectious Diseases

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Initiatives

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.publication-status

Published

pubs.volume

21

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Eichenberger BSI in Transplant AJT 2020.pdf
Size:
693.4 KB
Format:
Adobe Portable Document Format